From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
|Articles|November 1, 2016
Generic Cholesterol Drug Launched
Author(s)Jennifer Barrett, Assistant Editor
Rosuvastatin is the generic version of Crestor tablets from AstraZeneca.
Advertisement
Camber has announced the launch of Rosuvastatin, the generic version of Crestor tablets from AstraZeneca, in 5-, 10-, 20-, and 40-mg tablets. The drug is indicated to treat high cholesterol and triglyceride levels.
Rosuvastatin will be available in 90-count bottles of 5-, 10-, and 20-mg dosage strengths, as well as 30-count bottles of a 40-mg dosage strength.
Advertisement
Related to this article
From insurance delays to injection concerns, pharmacists can help patients navigate the first month and avoid preventable treatment interruptions.
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
Pharmacy Times featured experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Phase 3 data show pembrolizumab beats chemotherapy, offering durable first-line control with fewer severe toxicities and chemo-free potential.
In an interview with Pharmacy Times, Danielle Roman, PharmD, BCOP, FHOPA, discusses NCCN breast cancer guideline updates involving ESR1 mutation testing, targeted therapies, and pharmacists’ roles in monitoring, patient counseling, and treatment access.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Specialty pharmacy liaisons improve breast cancer care by easing access barriers, managing side effects, boosting adherence, and navigating new therapies and policies.
Advertisement
Advertisement
Trending on Pharmacy Times
1
PCSK9 Inhibition Lowers LDL-C in Patients With Kidney Disease
2
GLP-1 RAs Tied to Lower Kidney Failure Risk in Patients With Obesity, CKD
3
Walgreens Adds Pharmacist Outreach, Coverage Help for GLP-1s
4
The Growing Role the Specialty Pharmacy Team Plays in Helping Breast Cancer Patients Navigate Treatment
5